Category:
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Neuspera Medical Raises $23 Million in Series D Financing
Neuspera Medical notes this round will fund the company though expected U.S. Food and Drug Association (FDA) premarket approval (PMA) of the Neuspera System, the discreet, minimally invasive, ultra-miniaturized implant designed to provide patients personal control and relief from urinary urge incontinence (UUI), a symptom of overactive bladder (OAB).
Spotlight Medical Secures €6.2M in Seed Funding to Enhance Cancer Treatment Strategies with AI-Powered Prognosis Tests
This funding will enable Spotlight Medical to bring its first prognosis test to the clinic, marking a significant milestone in the commercialization of AI-based solutions for cancer treatment. By leveraging decades of patient treatment data, Spotlight Medical aims to ensure that no patient is over or undertreated, ultimately improving cancer outcomes.
Teknova Announces $15.4 Million Private Placement
eknova currently intends to use the net proceeds from the private placement for general corporate purposes.
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent builds on Momentum with New $3.6 Million NIH SBIR Grant to fund U.S. clinical trial of breakthrough medical device showing promise in improving dialysis patient outcomes.
Qure.ai Reports Strategic Investment by Merck Global Health Innovation Fund to Boost Innovation of Healthcare AI
Prashant Warier, Co-founder and CEO of Qure.ai, “This strategic investment in Qure.ai from the Merck Global Health Innovation Fund will enable us to expedite our work in foundation models and expand the reach of our AI both geographically and demographically.”
Opthea Limited Successfully Completes Placement and Institutional Component of Entitlement Offer Raising A$171.5 million (US$113.2m¹)
“We appreciate the strong support from our shareholders, and from new investors, who share our belief that sozinibercept has the potential to transform patient outcomes with superior vision gains, which continues to be a significant unmet need in wet AMD,” said Frederic Guerard, PharmD, Chief Executive Officer of Opthea Limited.
InduPro Announces $85 Million Series A Financing
InduPro notes the financing will support the advancement of the first expected clinical product candidate targeting cancer tissue based on the proximity of co-targeted pairs, from preclinical development to an expected IND filing in Q4 2025 for a Phase 1 clinical trial. It will also fuel a pipeline of novel bispecific antibodies and antibody drug conjugates (ADCs) that utilizes protein proximity for identification of novel tumor selective target pairings.
Powered By MRP Raises Series A Funding from Aries Capital Partners and Swell Collective
The Series A investment marks a pivotal moment in the company's growth trajectory as it brings together unparalleled expertise and resources to accelerate the company’s expansion plans and market presence.
Nuclera Awarded £1.14M Innovate UK Funding for Development of eProtein Discovery
The funding, made up of a £790k flexible, agile, scalable, and sustainable technologies (FASST) grant awarded in collaboration with DeepMirror, and a £350k Engineering Biology grant, to further develop the platform, including evaluations by Dr Konstantinos Beis, an independent expert from Imperial College London, and Dr Andrew Quigley from Diamond Light Source.
Medical Device News Magazine
